{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:48:06Z","timestamp":1790563686587,"version":"4.1.0"},"reference-count":180,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014974","name":"Institute of Biophysics, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902891"],"award-info":[{"award-number":["81902891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011456"],"award-info":[{"award-number":["2019A1515011456"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002912","name":"Government of Guangdong Province","doi-asserted-by":"publisher","award":["2020GDASYL-20200202001"],"award-info":[{"award-number":["2020GDASYL-20200202001"]}],"id":[{"id":"10.13039\/501100002912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002912","name":"Government of Guangdong Province","doi-asserted-by":"publisher","award":["2021TQ060920"],"award-info":[{"award-number":["2021TQ060920"]}],"id":[{"id":"10.13039\/501100002912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002912","name":"Government of Guangdong Province","doi-asserted-by":"publisher","award":["2022GDASZH-2022010110"],"award-info":[{"award-number":["2022GDASZH-2022010110"]}],"id":[{"id":"10.13039\/501100002912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bcp.2023.115993","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T10:25:51Z","timestamp":1703499951000},"page":"115993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Research progress on phosphatidylinositol 4-kinase inhibitors"],"prefix":"10.1016","volume":"220","author":[{"given":"Gang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengqin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1152\/physrev.00028.2012","article-title":"Phosphoinositides: tiny lipids with giant impact on cell regulation[J]","volume":"93","author":"Balla","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2023.115993_b0010","first-page":"1","article-title":"Beyond PI3Ks: targeting phosphoinositide kinases in disease[J]","author":"Burke","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"29","key":"10.1016\/j.bcp.2023.115993_b0015","doi-asserted-by":"crossref","first-page":"18358","DOI":"10.1074\/jbc.272.29.18358","article-title":"Isolation and molecular cloning of wortmannin-sensitive bovine type III phosphatidylinositol 4-kinases[J]","volume":"272","author":"Balla","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yexcr.2015.03.028","article-title":"Phosphatidylinositol 4-kinases: function, structure, and inhibition[J]","volume":"337","author":"Boura","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10409238.2013.853024","article-title":"Cinderella story: PI4P goes from precursor to key signaling molecule[J]","volume":"49","author":"Tan","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbamcr.2005.04.013","article-title":"The role of the phosphoinositides at the Golgi complex[J]","volume":"1744","author":"De Matteis","year":"2005","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Res."},{"issue":"10","key":"10.1016\/j.bcp.2023.115993_b0035","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.15252\/embr.201438841","article-title":"The crystal structure of the phosphatidylinositol 4-kinase IIalpha[J]","volume":"15","author":"Baumlova","year":"2014","journal-title":"EMBO Rep."},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tcb.2006.05.003","article-title":"Phosphatidylinositol 4-kinases: old enzymes with emerging functions[J]","volume":"16","author":"Balla","year":"2006","journal-title":"Trends Cell Biol."},{"issue":"41","key":"10.1016\/j.bcp.2023.115993_b0045","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer: variations on a theme[J]","volume":"27","author":"Yuan","year":"2008","journal-title":"Oncogene"},{"issue":"26","key":"10.1016\/j.bcp.2023.115993_b0050","doi-asserted-by":"crossref","first-page":"21856","DOI":"10.1074\/jbc.M112.348094","article-title":"Phosphatidylinositol 4-kinase IIalpha is palmitoylated by Golgi-localized palmitoyltransferases in cholesterol-dependent manner[J]","volume":"287","author":"Lu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bcp.2023.115993_b0055","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1091\/mbc.e10-05-0424","article-title":"Oxysterol binding protein-dependent activation of sphingomyelin synthesis in the golgi apparatus requires phosphatidylinositol 4-kinase IIalpha[J]","volume":"21","author":"Banerji","year":"2010","journal-title":"Mol. Biol. Cell"},{"issue":"Pt 17","key":"10.1016\/j.bcp.2023.115993_b0060","first-page":"3745","article-title":"Endosomal sorting of VAMP3 is regulated by PI4K2A[J]","volume":"127","author":"Jovic","year":"2014","journal-title":"J. Cell Sci."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2023.115993_b0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1242\/jcs.02752","article-title":"Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor[J]","volume":"119","author":"Minogue","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2023.115993_b0070","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1038\/ncomms4552","article-title":"Molecular insights into the membrane-associated phosphatidylinositol 4-kinase IIalpha[J]","volume":"5","author":"Zhou","year":"2014","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.bcp.2023.115993_b0075","doi-asserted-by":"crossref","first-page":"12775","DOI":"10.1074\/jbc.M110.178616","article-title":"Stabilization of phosphatidylinositol 4-kinase type IIbeta by interaction with Hsp90[J]","volume":"286","author":"Jung","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"Pt 7","key":"10.1016\/j.bcp.2023.115993_b0080","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1107\/S1399004715009505","article-title":"The high-resolution crystal structure of phosphatidylinositol 4-kinase IIbeta and the crystal structure of phosphatidylinositol 4-kinase IIalpha containing a nucleoside analogue provide a structural basis for isoform-specific inhibitor design[J]","volume":"71","author":"Klima","year":"2015","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bcp.2023.115993_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174300","article-title":"Research progress of phosphatidylinositol 4-kinase and its inhibitors in inflammatory diseases[J]","volume":"907","author":"Li","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1042\/BST20150219","article-title":"Type III phosphatidylinositol 4 kinases: structure, function, regulation, signalling and involvement in disease[J]","volume":"44","author":"Dornan","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bcp.2023.115993_b0095","doi-asserted-by":"crossref","first-page":"23641","DOI":"10.1038\/srep23641","article-title":"Structural insights and in vitro reconstitution of membrane targeting and activation of human PI4KB by the ACBD3 protein[J]","volume":"6","author":"Klima","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.devcel.2013.11.012","article-title":"Structural insights into assembly and regulation of the plasma membrane phosphatidylinositol 4-kinase complex[J]","volume":"28","author":"Wu","year":"2014","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.devcel.2006.09.001","article-title":"Phosphatidylinositol 4-phosphate formation at ER exit sites regulates ER export[J]","volume":"11","author":"Blumental-perry","year":"2006","journal-title":"Dev. Cell"},{"issue":"6","key":"10.1016\/j.bcp.2023.115993_b0110","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1083\/jcb.201206095","article-title":"PtdIns4P synthesis by PI4KIIIalpha at the plasma membrane and its impact on plasma membrane identity[J]","volume":"199","author":"Nakatsu","year":"2012","journal-title":"J. Cell Biol."},{"issue":"17","key":"10.1016\/j.bcp.2023.115993_b0115","doi-asserted-by":"crossref","first-page":"9909","DOI":"10.1128\/JVI.01063-14","article-title":"Mapping of functional domains of the lipid kinase phosphatidylinositol 4-kinase type III alpha involved in enzymatic activity and hepatitis C virus replication[J]","volume":"88","author":"Harak","year":"2014","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115993_b0120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1083\/jcb.200804003","article-title":"Assembly of the PtdIns 4-kinase Stt4 complex at the plasma membrane requires Ypp1 and Efr3[J]","volume":"183","author":"Baird","year":"2008","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0125","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jaci.2013.06.013","article-title":"Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias[J]","volume":"132","author":"Chen","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0130","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/emboj.2011.429","article-title":"ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites[J]","volume":"31","author":"Sasaki","year":"2012","journal-title":"EMBO J."},{"issue":"22","key":"10.1016\/j.bcp.2023.115993_b0135","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1073\/pnas.0903001106","article-title":"Calneurons provide a calcium threshold for trans-Golgi network to plasma membrane trafficking[J]","volume":"106","author":"Mikhaylova","year":"2009","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.bcp.2023.115993_b0140","first-page":"1205","article-title":"Molecular structure and target recognition of neuronal calcium sensor proteins[J]","volume":"1820","author":"Ames","year":"2012","journal-title":"BBA"},{"issue":"4","key":"10.1016\/j.bcp.2023.115993_b0145","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/pro.2879","article-title":"Using hydrogen deuterium exchange mass spectrometry to engineer optimized constructs for crystallization of protein complexes: case study of PI4K3B with Rab11","volume":"25","author":"Fowler","year":"2016","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2012.06.009","article-title":"Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancer[J]","volume":"325","author":"Waugh","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2023.115993_b0155","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnmol.2019.00208","article-title":"Phosphoinositides: regulators of nervous system function in health and disease[J]","volume":"12","author":"Raghu","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.molcel.2018.08.005","article-title":"Structural basis for regulation of phosphoinositide kinases and their involvement in human disease[J]","volume":"71","author":"Burke","year":"2018","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.bcp.2023.115993_b0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tcb.2011.05.005","article-title":"Membrane-trafficking sorting hubs: cooperation between PI4P and small GTPases at the trans-Golgi network[J]","volume":"21","author":"Santiago-tirado","year":"2011","journal-title":"Trends Cell Biol."},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0170","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1091\/mbc.e06-10-0897","article-title":"PI4P promotes the recruitment of the GGA adaptor proteins to the trans-Golgi network and regulates their recognition of the ubiquitin sorting signal[J]","volume":"18","author":"Wang","year":"2007","journal-title":"Mol. Biol. Cell"},{"issue":"10","key":"10.1016\/j.bcp.2023.115993_b0175","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrm2971","article-title":"Non-vesicular lipid transport by lipid-transfer proteins and beyond[J]","volume":"11","author":"Lev","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115993_b0180","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cell.2013.09.056","article-title":"A four-step cycle driven by PI (4)P hydrolysis directs sterol\/PI (4)P exchange by the ER-Golgi tether OSBP[J]","volume":"155","author":"Mesmin","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0185","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1073\/pnas.0709191105","article-title":"Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide[J]","volume":"105","author":"Kudo","year":"2008","journal-title":"PNAS"},{"issue":"6968","key":"10.1016\/j.bcp.2023.115993_b0190","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature02188","article-title":"Molecular machinery for non-vesicular trafficking of ceramide[J]","volume":"426","author":"Hanada","year":"2003","journal-title":"Nature"},{"issue":"7158","key":"10.1016\/j.bcp.2023.115993_b0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature06097","article-title":"Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide[J]","volume":"449","author":"D'Angelo","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tcb.2010.10.002","article-title":"Coordination of Golgi functions by phosphatidylinositol 4-kinases[J]","volume":"21","author":"Graham","year":"2011","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cell.2009.07.052","article-title":"GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding[J]","volume":"139","author":"Dippole","year":"2009","journal-title":"Cell"},{"issue":"42","key":"10.1016\/j.bcp.2023.115993_b0210","doi-asserted-by":"crossref","first-page":"30029","DOI":"10.1074\/jbc.M113.497180","article-title":"Functional characterization of human myosin-18A and its interaction with F-actin and GOLPH3[J]","volume":"288","author":"Taft","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2023.115993_b0215","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1091\/mbc.e12-07-0525","article-title":"GOLPH3L antagonizes GOLPH3 to determine Golgi morphology[J]","volume":"24","author":"Ng","year":"2013","journal-title":"Mol. Biol. Cell"},{"issue":"8","key":"10.1016\/j.bcp.2023.115993_b0220","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1158\/1078-0432.CCR-09-1695","article-title":"Signaling from the Golgi: mechanisms and models for Golgi phosphoprotein 3-mediated oncogenesis[J]","volume":"16","author":"Scott","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2023.115993_b0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ceb.2017.01.004","article-title":"Emerging themes of regulation at the Golgi[J]","volume":"45","author":"Makowski","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115993_b0230","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1158\/0008-5472.CAN-14-3081","article-title":"GOLPH3 links the Golgi, DNA damage, and cancer[J]","volume":"75","author":"Buschman","year":"2015","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0235","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.plipres.2013.04.002","article-title":"Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks[J]","volume":"52","author":"Clayton","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plipres.2009.12.001","article-title":"Phosphoinositide phosphatases in cell biology and disease[J]","volume":"49","author":"Liu","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bcp.2023.115993_b0245","article-title":"The chemistry and biology of phosphatidylinositol 4-phosphate at the plasma membrane[J]","volume":"40","author":"Batrounia","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"25","key":"10.1016\/j.bcp.2023.115993_b0250","doi-asserted-by":"crossref","first-page":"E3199","DOI":"10.1073\/pnas.1509119112","article-title":"Phosphoregulatory protein 14-3-3 facilitates SAC1 transport from the endoplasmic reticulum[J]","volume":"112","author":"Bajaj Pahuja","year":"2015","journal-title":"PNAS"},{"issue":"02","key":"10.1016\/j.bcp.2023.115993_b0255","first-page":"414","article-title":"Research progress on small molecule kinase inhibitors[J]","volume":"56","author":"Chun-ting","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.bcp.2023.115993_b0260","first-page":"1232","article-title":"Progress in the design of selective ATP-competitive kinase inhibitors[J]","volume":"12","author":"Xiao-qiang","year":"2007","journal-title":"Acta Pharm. Sin."},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0265","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria[J]","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"7479","key":"10.1016\/j.bcp.2023.115993_b0270","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI (4)K to eliminate malaria[J]","volume":"504","author":"Mcnamara","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0275","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/AAC.03080-15","article-title":"PI4 Kinase is a prophylactic but not radical curative target in plasmodium vivax-type malaria parasites[J]","volume":"60","author":"Zeeman","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.bcp.2023.115993_b0280","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/ml500244m","article-title":"Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages[J]","volume":"5","author":"Zou","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bcp.2023.115993_b0285","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1021\/acs.jmedchem.8b00329","article-title":"Plasmodial kinase inhibitors: license to cure? [J]","volume":"61","author":"Cabrera","year":"2018","journal-title":"J. Med. Chem."},{"issue":"7479","key":"10.1016\/j.bcp.2023.115993_b0290","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI (4) K to eliminate malaria[J]","volume":"504","author":"McNamara","year":"2013","journal-title":"Nature"},{"issue":"387","key":"10.1016\/j.bcp.2023.115993_b0295","doi-asserted-by":"crossref","first-page":"eaad9735","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase[J]","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.bcp.2023.115993_b0300","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1093\/cid\/ciaa368","article-title":"A Phase 1, placebo-controlled, randomized, single ascending dose study and a volunteer infection study to characterize the safety, pharmacokinetics, and antimalarial activity of the plasmodium phosphatidylinositol 4-kinase inhibitor MMV390048[J]","volume":"71","author":"Mccarthy","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.bcp.2023.115993_b0305","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/bdr2.2012","article-title":"Malarial PI4K inhibitor induced diaphragmatic hernias in rat: potential link with mammalian kinase inhibition[J]","volume":"114","author":"Demarta-Gatsi","year":"2022","journal-title":"Birth Defects Research"},{"key":"10.1016\/j.bcp.2023.115993_b0310","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.biopha.2016.07.048","article-title":"Homology modeling and virtual screening for inhibitors of lipid kinase PI(4)K from Plasmodium[J]","volume":"83","author":"Ren","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bcp.2023.115993_b0315","doi-asserted-by":"crossref","first-page":"e00012","DOI":"10.1128\/AAC.00012-18","article-title":"UCT943, a next-generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria[J]","volume":"62","author":"Brunschwig","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"21","key":"10.1016\/j.bcp.2023.115993_b0320","doi-asserted-by":"crossref","first-page":"9890","DOI":"10.1021\/acs.jmedchem.6b01265","article-title":"Identification of a potential antimalarial drug candidate from a series of 2-aminopyrazines by optimization of aqueous solubility and potency across the parasite Life Cycle[J]","volume":"59","author":"Le Manach","year":"2016","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115993_b0325","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/pro.2879","article-title":"Using hydrogen deuterium exchange mass spectrometry to engineer optimized constructs for crystallization of protein complexes: case study of PI4K3B with Rab11[J]","volume":"25","author":"Fowler","year":"2016","journal-title":"Protein Sci."},{"issue":"7625","key":"10.1016\/j.bcp.2023.115993_b0330","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature19804","article-title":"Diversity-oriented synthesis yields novel multistage antimalarial inhibitors[J]","volume":"538","author":"Kato","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115993_b0335","doi-asserted-by":"crossref","unstructured":"X. Liang, Z. Jiang, Z. Huang Z, et al. Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3, 3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI (4) K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium[J]. European Journal of Medicinal Chemistry, 2019, 188: 112012-112012.","DOI":"10.1016\/j.ejmech.2019.112012"},{"key":"10.1016\/j.bcp.2023.115993_b0340","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ncomms1558","article-title":"Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum[J]","volume":"2","author":"Solyakov","year":"2011","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0345","doi-asserted-by":"crossref","first-page":"e54022","DOI":"10.15252\/embr.202154022","article-title":"PI4-kinase and PfCDPK7 signaling regulate phospholipid biosynthesis in Plasmodium falciparum[J]","volume":"23","author":"Maurya","year":"2022","journal-title":"EMBO Rep."},{"issue":"10063","key":"10.1016\/j.bcp.2023.115993_b0350","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000\u201315: an updated systematic analysis with implications for the Sustainable Development Goals[J]","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"9888","key":"10.1016\/j.bcp.2023.115993_b0355","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study[J]","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bcp.2023.115993_b0360","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1016\/S2214-109X(15)00151-5","article-title":"Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)[J]","volume":"3","author":"Platts-mills","year":"2015","journal-title":"Lancet Glob. Health"},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0365","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium[J]","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"11","key":"10.1016\/j.bcp.2023.115993_b0370","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.pt.2018.07.009","article-title":"Genetic diversity and population structure of cryptosporidium[J]","volume":"34","author":"Feng","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bcp.2023.115993_b0375","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2334-9-195","article-title":"High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial[J]","volume":"9","author":"Amadi","year":"2009","journal-title":"BMC Infect. Dis."},{"issue":"9343","key":"10.1016\/j.bcp.2023.115993_b0380","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","article-title":"Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial[J]","volume":"360","author":"Amadi","year":"2002","journal-title":"Lancet"},{"issue":"7658","key":"10.1016\/j.bcp.2023.115993_b0385","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI (4) K inhibitor is a drug candidate for cryptosporidiosis[J]","volume":"546","author":"Manjunatha","year":"2017","journal-title":"Nature"},{"issue":"7658","key":"10.1016\/j.bcp.2023.115993_b0390","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI (4)K inhibitor is a drug candidate for cryptosporidiosis[J]","volume":"546","author":"Manjunatha","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2023.115993_b0395","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.pt.2017.07.004","article-title":"New tools for cryptosporidium lead to new hope for cryptosporidiosis[J]","volume":"33","author":"Ward","year":"2017","journal-title":"Trends Parasitol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0400","doi-asserted-by":"crossref","first-page":"e00052","DOI":"10.1128\/mBio.00052-20","article-title":"Defining stage-specific activity of potent new inhibitors of cryptosporidium parvum growth in vitro[J]","volume":"11","author":"Funkhouser-Jones","year":"2020","journal-title":"MBio"},{"issue":"4","key":"10.1016\/j.bcp.2023.115993_b0405","doi-asserted-by":"crossref","first-page":"e01505","DOI":"10.1128\/AAC.01505-17","article-title":"A novel piperazine-based drug lead for cryptosporidiosis from the medicines for malaria venture open-access malaria Box[J]","volume":"62","author":"Jumani","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10110","key":"10.1016\/j.bcp.2023.115993_b0410","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human african trypanosomiasis[J]","volume":"390","author":"Buscher","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0415","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/S1473-3099(19)30612-7","article-title":"New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice[J]","volume":"20","author":"Lindner","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0420","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/EC.00107-07","article-title":"Phosphatidylinositol 4-kinase III-beta is required for Golgi maintenance and cytokinesis in Trypanosoma brucei[J]","volume":"6","author":"Rodgers","year":"2007","journal-title":"Eukaryot. Cell"},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0425","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bbrc.2009.10.086","article-title":"The TryPIKinome of five human pathogenic trypanosomatids: trypanosoma brucei, Trypanosoma cruzi, Leishmania major, Leishmania braziliensis and Leishmania infantum\u2013new tools for designing specific inhibitors[J]","volume":"390","author":"Bahia","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2023.115993_b0430","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.micro.112408.134012","article-title":"Organelle-like membrane compartmentalization of positive-strand RNA virus replication factories[J]","volume":"64","author":"Den Boon","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0435","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tibs.2012.03.004","article-title":"Phosphatidylinositol 4-kinases: hostages harnessed to build panviral replication platforms[J]","volume":"37","author":"Altan-Bonnet","year":"2012","journal-title":"Trends Biochem. Sci"},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0440","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.tim.2016.02.017","article-title":"Fat(al) attraction: picornaviruses usurp lipid transfer at membrane contact sites to create replication Organelles[J]","volume":"24","author":"Van Der Schaar","year":"2016","journal-title":"Trends Microbiol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0445","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/tra.12841","article-title":"Molecular mechanisms of PI4K regulation and their involvement in viral replication","volume":"24","author":"McPhail","year":"2023","journal-title":"Traffic"},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0450","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/12993","article-title":"ARF mediates recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of PtdIns(4,5)P2 on the Golgi complex[J]","volume":"1","author":"Godi","year":"1999","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0455","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.devcel.2006.06.005","article-title":"A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1[J]","volume":"11","author":"Wessels","year":"2006","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0460","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/embor.2008.221","article-title":"A COPI coat subunit interacts directly with an early-Golgi localized Arf exchange factor[J]","volume":"10","author":"Deng","year":"2009","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0465","doi-asserted-by":"crossref","first-page":"e02742","DOI":"10.1128\/mBio.02742-18","article-title":"ACBD3 is an essential pan-enterovirus host factor that mediates the interaction between viral 3A protein and cellular protein PI4KB[J]","volume":"10","author":"Lyoo","year":"2019","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0470","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.str.2016.11.021","article-title":"Kobuviral non-structural 3A proteins act as molecular harnesses to hijack the host ACBD3 protein[J]","volume":"25","author":"Klima","year":"2017","journal-title":"Structure"},{"issue":"20","key":"10.1016\/j.bcp.2023.115993_b0475","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1128\/JVI.00304-13","article-title":"The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication[J]","volume":"87","author":"Teoule","year":"2013","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0480","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cell.2010.03.050","article-title":"Viral reorganization of the secretory pathway generates distinct organelles for RNA replication[J]","volume":"141","author":"Hsu","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0485","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2010.12.002","article-title":"Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment[J]","volume":"9","author":"Reiss","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"18","key":"10.1016\/j.bcp.2023.115993_b0490","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1073\/pnas.0902693106","article-title":"Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication[J]","volume":"106","author":"Berger","year":"2009","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0495","doi-asserted-by":"crossref","first-page":"e00068","DOI":"10.1128\/mSphere.00068-16","article-title":"Mutations in encephalomyocarditis virus 3A protein uncouple the dependency of genome replication on host factors phosphatidylinositol 4-Kinase IIIalpha and oxysterol-binding protein[J]","volume":"1","author":"Dorobantu","year":"2016","journal-title":"mSphere."},{"issue":"9","key":"10.1016\/j.bcp.2023.115993_b0500","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.M113.531426","article-title":"Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate levels","volume":"289","author":"Bojjireddy","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2023.115993_b0505","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.bmcl.2015.05.093","article-title":"Discovery of potent, selective small molecule inhibitors of \u03b1-subtype of type III phosphatidylinositol-4-kinase (PI4K3A)[J]","volume":"25","author":"Raubo","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"40","key":"10.1016\/j.bcp.2023.115993_b0510","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1039\/C3CC48391F","article-title":"Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase \u03b1-but not \u03b2-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferation[J]","volume":"50","author":"Waring","year":"2014","journal-title":"Chem. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2023.115993_b0515","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cell.2006.03.035","article-title":"A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling[J]","volume":"125","author":"Knight","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0520","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1021\/acs.jmedchem.5b01311","article-title":"Design and structural characterization of potent and selective inhibitors of phosphatidylinositol 4 Kinase IIIbeta[J]","volume":"59","author":"Rutaganira","year":"2016","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0525","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/JVI.02249-10","article-title":"Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity[J]","volume":"85","author":"Arita","year":"2011","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115993_b0530","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1021\/acs.jmedchem.5b00499","article-title":"Highly selective phosphatidylinositol 4-Kinase IIIbeta inhibitors and structural insight into their mode of action[J]","volume":"58","author":"Mejdrova","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0535","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acs.jmedchem.6b01465","article-title":"Rational design of novel highly potent and selective phosphatidylinositol 4-Kinase IIIbeta (PI4KB) inhibitors as broad-spectrum antiviral agents and tools for chemical biology[J]","volume":"60","author":"Mejdrova","year":"2017","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2023.115993_b0540","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/j.bmcl.2014.07.015","article-title":"2-Alkyloxazoles as potent and selective PI4KIIIbeta inhibitors demonstrating inhibition of HCV replication[J]","volume":"24","author":"Keaney","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bcp.2023.115993_b0545","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/AAC.01175-13","article-title":"A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIbeta[J]","volume":"57","author":"Van Der Schaar","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bcp.2023.115993_b0550","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/cr.2012.129","article-title":"Coxsackievirus mutants that can bypass host factor PI4KIIIbeta and the need for high levels of PI4P lipids for replication[J]","volume":"22","author":"van der Schaar","year":"2012","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.bcp.2023.115993_b0555","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s10822-020-00327-9","article-title":"Novel phosphatidylinositol 4-kinases III beta (PI4KIIIbeta) inhibitors discovered by virtual screening using free energy models[J]","volume":"34","author":"Colodette","year":"2020","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0560","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21767\/2471-8084.100006","article-title":"Onco-Golgi: is fragmentation a gate to cancer progression? [J]","volume":"1","author":"Petrosyan","year":"2015","journal-title":"Biochem Mol Biol J"},{"issue":"17","key":"10.1016\/j.bcp.2023.115993_b0565","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1002\/pmic.200500072","article-title":"Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling[J]","volume":"5","author":"Nilsson","year":"2005","journal-title":"Proteomics"},{"issue":"12","key":"10.1016\/j.bcp.2023.115993_b0570","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based human protein Atlas[J]","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"17","key":"10.1016\/j.bcp.2023.115993_b0575","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/onc.2010.14","article-title":"PI4KIIalpha is a novel regulator of tumor growth by its action on angiogenesis and HIF-1alpha regulation[J]","volume":"29","author":"Li","year":"2010","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bcp.2023.115993_b0580","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s13238-014-0055-y","article-title":"Dual inhibition of EGFR at protein and activity level via combinatorial blocking of PI4KIIalpha as anti-tumor strategy[J]","volume":"5","author":"Li","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.bcp.2023.115993_b0585","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1038\/cddis.2010.84","article-title":"Differential effects of the phosphatidylinositol 4-kinases, PI4KIIalpha and PI4KIIIbeta, on Akt activation and apoptosis[J]","volume":"1","author":"Chu","year":"2010","journal-title":"Cell Death Dis."},{"issue":"5894","key":"10.1016\/j.bcp.2023.115993_b0590","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.1160741","article-title":"Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation[J]","volume":"321","author":"Pan","year":"2008","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bcp.2023.115993_b0595","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/embor.2012.164","article-title":"Phosphatidylinositol 4-kinase IIalpha function at endosomes is regulated by the ubiquitin ligase Itch[J]","volume":"13","author":"Mossinger","year":"2012","journal-title":"EMBO Rep."},{"issue":"22","key":"10.1016\/j.bcp.2023.115993_b0600","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1158\/0008-5472.CAN-17-0484","article-title":"PI-273, a substrate-competitive, specific small-molecule inhibitor of PI4KIIalpha, inhibits the growth of breast cancer Cells[J]","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0605","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1194\/jlr.D090159","article-title":"A large scale high-throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alpha[J]","volume":"60","author":"Sengupta","year":"2019","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0610","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.gastro.2008.03.024","article-title":"Tetraspanin CD81-regulated cell motility plays a critical role in intrahepatic metastasis of hepatocellular carcinoma[J]","volume":"135","author":"Mazzocca","year":"2008","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bcp.2023.115993_b0615","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.onc.1207287","article-title":"Tetraspanin CD81 is linked to ERK\/MAPKinase signaling by Shc in liver tumor cells[J]","volume":"23","author":"Carloni","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2023.115993_b0620","doi-asserted-by":"crossref","unstructured":"K. Rombouts, V. Carloni, Determination and characterization of tetraspanin-associated Phosphoinositide-4 kinases in primary and neoplastic liver cells[J]. Methods Mol Biol. 2016, 1376(203-212.","DOI":"10.1007\/978-1-4939-3170-5_17"},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0625","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BCJ20180732","article-title":"Silencing of type II phosphatidylinositol 4-kinase beta stabilizes prostate apoptosis response-4 and induces apoptosis in cancer cells[J]","volume":"476","author":"Chaudhry","year":"2019","journal-title":"Biochem. J"},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0630","first-page":"299","article-title":"Identification of genes related to invasion and metastasis in pancreatic cancer by cDNA representational difference analysis[J]","volume":"22","author":"Ishikawa","year":"2003","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0635","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41388-018-0448-0","article-title":"A novel cross-talk between CXCR4 and PI4KIIIalpha in prostate cancer cells[J]","volume":"38","author":"Sbrissa","year":"2019","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0640","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/1541-7786.MCR-10-0200","article-title":"A sensitized RNA interference screen identifies a novel role for the PI3K p110gamma isoform in medulloblastoma cell proliferation and chemoresistance[J]","volume":"9","author":"Guerreiro","year":"2011","journal-title":"Mol. Cancer Res."},{"issue":"12","key":"10.1016\/j.bcp.2023.115993_b0645","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1096\/fj.06-6239com","article-title":"Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance[J]","volume":"20","author":"Giroux","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2023.115993_b0650","doi-asserted-by":"crossref","unstructured":"Kwon J, Kim D H, Park J M, et al. Targeting phosphatidylinositol 4-kinase III\u03b1 for radiosensitization: A potential model of drug repositioning using an anti-hepatitis C viral agent[J]. International Journal of Radiation Oncology* Biology* Physics, 2016, 96(4): 867-876.","DOI":"10.1016\/j.ijrobp.2016.08.007"},{"issue":"66","key":"10.1016\/j.bcp.2023.115993_b0655","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.22778","article-title":"Inhibition of PI4K III\u03b1 radiosensitizes in human tumor xenograft and immune-competent syngeneic murine tumor model[J]","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2023.115993_b0660","doi-asserted-by":"crossref","first-page":"12148","DOI":"10.1038\/ncomms12148","article-title":"Golgi membrane fission requires the CtBP1-S\/BARS-induced activation of lysophosphatidic acid acyltransferase delta[J]","volume":"7","author":"Pagliuso","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0665","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ncb1119","article-title":"FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P[J]","volume":"6","author":"Godi","year":"2004","journal-title":"Nat. Cell Biol."},{"issue":"13","key":"10.1016\/j.bcp.2023.115993_b0670","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1073\/pnas.1615163114","article-title":"Conserved role for Gga proteins in phosphatidylinositol 4-kinase localization to the trans-Golgi network[J]","volume":"114","author":"Daboussi","year":"2017","journal-title":"PNAS"},{"issue":"33","key":"10.1016\/j.bcp.2023.115993_b0675","doi-asserted-by":"crossref","first-page":"30315","DOI":"10.1074\/jbc.M201132200","article-title":"Mechanisms underlying the neuronal calcium sensor-1-evoked enhancement of exocytosis in PC12 cells[J]","volume":"277","author":"Koizumi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115993_b0680","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnmol.2019.00056","article-title":"Emerging roles of neuronal Ca (2+) sensor-1 in cardiac and neuronal tissues: A mini review[J]","volume":"12","author":"Nakamura","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"17","key":"10.1016\/j.bcp.2023.115993_b0685","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.yexcr.2011.08.002","article-title":"The lipid kinase PI4KIIIbeta and the eEF1A2 oncogene co-operate to disrupt three-dimensional in vitro acinar morphogenesis[J]","volume":"317","author":"Pinke","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0690","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2407-5-113","article-title":"Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours[J]","volume":"12","author":"Tomlinson","year":"2005","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0695","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10549-006-9315-8","article-title":"Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer[J]","volume":"102","author":"Kulkarni","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0700","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng904","article-title":"Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer[J]","volume":"31","author":"Anand","year":"2002","journal-title":"Nat. Genet."},{"issue":"527","key":"10.1016\/j.bcp.2023.115993_b0705","doi-asserted-by":"crossref","first-page":"eaax3772","DOI":"10.1126\/scitranslmed.aax3772","article-title":"PI4KIIIbeta is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma[J]","volume":"12","author":"Tan","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.bcp.2023.115993_b0710","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1158\/1541-7786.MCR-13-0604","article-title":"The lipid kinase PI4KIIIbeta is highly expressed in breast tumors and activates Akt in cooperation with Rab11a[J]","volume":"12","author":"Morrow","year":"2014","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0715","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/cas.12968","article-title":"Regulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer[J]","volume":"107","author":"Ijuin","year":"2016","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.bcp.2023.115993_b0720","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1158\/0008-5472.CAN-13-2441","article-title":"Phosphatidylinositol 4-phosphate in the Golgi apparatus regulates cell-cell adhesion and invasive cell migration in human breast cancer[J]","volume":"74","author":"Tokuda","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2023.115993_b0725","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.abb.2011.09.005","article-title":"Epigallocatechin gallate (EGCG) inhibits type II phosphatidylinositol 4-kinases: a key component in pathways of phosphoinositide turnover[J]","volume":"516","author":"Sinha","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0730","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.bcp.2005.07.003","article-title":"Resveratrol inhibits type II phosphatidylinositol 4-kinase: a key component in pathways of phosphoinositide turn over[J]","volume":"70","author":"Srivastava","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115993_b0735","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-014-2041-3","article-title":"Piperine inhibits type II phosphatidylinositol 4-kinases: a key component in phosphoinositides turnover[J]","volume":"393","author":"Bojjireddy","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0740","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.abb.2013.07.017","article-title":"Sanguinarine suppresses IgE induced inflammatory responses through inhibition of type II PtdIns 4-kinase(s)[J]","volume":"537","author":"Bojjireddy","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"issue":"34","key":"10.1016\/j.bcp.2023.115993_b0745","doi-asserted-by":"crossref","first-page":"21451","DOI":"10.1074\/jbc.273.34.21451","article-title":"Newly synthesized phosphatidylinositol phosphates are required for synaptic norepinephrine but not glutamate or gamma-aminobutyric acid (GABA) release[J]","volume":"273","author":"Khvotchev","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.bcp.2023.115993_b0750","doi-asserted-by":"crossref","first-page":"10303","DOI":"10.1073\/pnas.0504487102","article-title":"Neuronal calcium sensor-1 potentiates glucose-dependent exocytosis in pancreatic beta cells through activation of phosphatidylinositol 4-kinase beta[J]","volume":"102","author":"Gromada","year":"2005","journal-title":"PNAS"},{"issue":"Pt 11","key":"10.1016\/j.bcp.2023.115993_b0755","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1242\/jcs.115.11.2399","article-title":"Neuronal calcium sensor-1 binds to regulated secretory organelles and functions in basal and stimulated exocytosis in PC12 cells[J]","volume":"115","author":"Scalettar","year":"2002","journal-title":"J. Cell Sci."},{"issue":"8","key":"10.1016\/j.bcp.2023.115993_b0760","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1600-0854.2007.00594.x","article-title":"Specificity, promiscuity and localization of ARF protein interactions with NCS-1 and phosphatidylinositol-4 kinase-III beta[J]","volume":"8","author":"Haynes","year":"2007","journal-title":"Traffic"},{"issue":"10","key":"10.1016\/j.bcp.2023.115993_b0765","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.4049\/jimmunol.171.10.5320","article-title":"Neuronal calcium sensor-1 and phosphatidylinositol 4-kinase beta regulate IgE receptor-triggered exocytosis in cultured mast cells[J]","volume":"171","author":"Kapp-Barnea","year":"2003","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0770","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1523\/JNEUROSCI.22-07-02427.2002","article-title":"Alterations in exocytosis induced by neuronal Ca2+ sensor-1 in bovine chromaffin cells[J]","volume":"22","author":"Pan","year":"2002","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0775","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1074\/jbc.M413090200","article-title":"Interaction of neuronal calcium sensor-1 and ADP-ribosylation factor 1 allows bidirectional control of phosphatidylinositol 4-kinase beta and trans-Golgi network-plasma membrane traffic[J]","volume":"280","author":"Haynes","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2023.115993_b0780","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1073\/pnas.0230488100","article-title":"Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles[J]","volume":"100","author":"Guo","year":"2003","journal-title":"PNAS"},{"issue":"Pt 2","key":"10.1016\/j.bcp.2023.115993_b0785","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/bj3630289","article-title":"Regulation and recruitment of phosphatidylinositol 4-kinase on immature secretory granules is independent of ADP-ribosylation factor 1[J]","volume":"363","author":"Panaretou","year":"2002","journal-title":"Biochem. J"},{"issue":"11","key":"10.1016\/j.bcp.2023.115993_b0790","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1074\/jbc.C000861200","article-title":"A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans[J]","volume":"276","author":"Barylko","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0795","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(03)00603-2","article-title":"Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the Golgi[J]","volume":"114","author":"Wang","year":"2003","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.bcp.2023.115993_b0800","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1091\/mbc.e11-07-0592","article-title":"The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse[J]","volume":"22","author":"Larimore","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0805","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/01677063.2018.1502762","article-title":"Type II phosphatidylinositol 4-kinase regulates nerve terminal growth and synaptic vesicle recycling[J]","volume":"32","author":"Cantarutti","year":"2018","journal-title":"J. Neurogenet."},{"issue":"19","key":"10.1016\/j.bcp.2023.115993_b0810","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1523\/JNEUROSCI.3567-16.2017","article-title":"Downregulation of RBO-PI4KIIIalpha facilitates Abeta42 secretion and ameliorates neural deficits in Abeta42-expressing drosophila[J]","volume":"37","author":"Zhang","year":"2017","journal-title":"J. Neurosci."},{"issue":"28","key":"10.1016\/j.bcp.2023.115993_b0815","doi-asserted-by":"crossref","first-page":"11535","DOI":"10.1073\/pnas.0903011106","article-title":"Loss of phosphatidylinositol 4-kinase 2alpha activity causes late onset degeneration of spinal cord axons[J]","volume":"106","author":"Simons","year":"2009","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0820","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/17482968.2010.543689","article-title":"Screening for mutations in the phosphatidylinositol 4-kinase 2-alpha gene in autosomal recessive hereditary spastic paraplegia[J]","volume":"12","author":"Cleeter","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"issue":"11","key":"10.1016\/j.bcp.2023.115993_b0825","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/sj.mp.4002080","article-title":"An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia[J]","volume":"13","author":"Jungerius","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0830","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.b.30821","article-title":"Failure to confirm the association between the PIK4CA gene and schizophrenia in a Japanese population[J]","volume":"150B","author":"Kanahara","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"16","key":"10.1016\/j.bcp.2023.115993_b0835","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jpsychires.2009.05.004","article-title":"A case-control association study and family-based expression analysis of the bipolar disorder candidate gene PI4K2B[J]","volume":"43","author":"Houlihan","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.bcp.2023.115993_b0840","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1471-4159.1987.tb05619.x","article-title":"Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains[J]","volume":"48","author":"Stokes","year":"1987","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.bcp.2023.115993_b0845","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0006-3223(98)00073-0","article-title":"Reductions in brain phosphatidylinositol kinase activities in Alzheimer's disease[J]","volume":"45","author":"Zubenko","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2023.115993_b0850","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neulet.2005.11.026","article-title":"Attenuation of amyloid beta (Abeta)-induced inhibition of phosphatidylinositol 4-kinase activity by Abeta fragments, Abeta20-29 and Abeta31-35[J]","volume":"396","author":"Wu","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.bcp.2023.115993_b0855","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neulet.2007.04.022","article-title":"Protective effects of Abeta-derived tripeptide, Abeta (32\u201334), on Abeta (1\u201342)-induced phosphatidylinositol 4-kinase inhibition and neurotoxicity[J]","volume":"419","author":"Xiong","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.bcp.2023.115993_b0860","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease[J]","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.bcp.2023.115993_b0865","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease[J]","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"issue":"6060","key":"10.1016\/j.bcp.2023.115993_b0870","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1126\/science.1213210","article-title":"Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast[J]","volume":"334","author":"Treusch","year":"2011","journal-title":"Science"},{"issue":"25","key":"10.1016\/j.bcp.2023.115993_b0875","doi-asserted-by":"crossref","first-page":"21279","DOI":"10.1074\/jbc.M111.338376","article-title":"Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis[J]","volume":"287","author":"Xiao","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.bcp.2023.115993_b0880","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1093\/hmg\/ddv117","article-title":"Germline recessive mutations in PI4KA are associated with perisylvian polymicrogyria, cerebellar hypoplasia and arthrogryposis[J]","volume":"24","author":"Pagnamenta","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.bcp.2023.115993_b0885","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ibd\/izz259","article-title":"Very early onset inflammatory bowel disease: a clinical approach with a focus on the role of genetics and underlying immune deficiencies[J]","volume":"26","author":"Ouahed","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.bcp.2023.115993_b0890","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1053\/j.gastro.2014.01.015","article-title":"Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease[J]","volume":"146","author":"Avitzur","year":"2014","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.bcp.2023.115993_b0895","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1021\/acs.jmedchem.8b00521","article-title":"Discovery of a potent, orally bioavailable PI4KIIIbeta inhibitor (UCB9608) able to significantly prolong allogeneic organ engraftment in vivo[J]","volume":"61","author":"Reuberson","year":"2018","journal-title":"J. Med. Chem."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2023.115993_b0900","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1113\/jphysiol.2007.132720","article-title":"Dual control of cardiac Na+ Ca2+ exchange by PIP (2): analysis of the surface membrane fraction by extracellular cysteine PEGylation[J]","volume":"582","author":"Shen","year":"2007","journal-title":"J. Physiol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223005865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223005865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:17:39Z","timestamp":1762096659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223005865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":180,"alternative-id":["S0006295223005865"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115993","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress on phosphatidylinositol 4-kinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115993"}}